Announced Thu, 2 Jul · 21:25 IST
Dipna Pharmachem FY26 PAT jumps 170% to Rs 2.63 cr, ops cash flow negative
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+0.0%1-day move
₹6.00
prior close
₹6.06
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
—+3.1——+0.0-4.5-6.3+5.0-3.2-7.2-16.0———
Up moveDown movePending
AI summary
Dipna Pharmachem reported FY26 revenue of Rs 12,908 lakhs (up 3.3% YoY) and net profit of Rs 263 lakhs (up 170% from Rs 97 lakhs). EPS rose to Rs 1.00 from Rs 0.41. However, operating cash flow was deeply negative at Rs 1,832 lakhs versus negative Rs 919 lakhs last year. Q4 revenue was weak at Rs 202 lakhs. Board also confirmed no deviation in use of preferential warrant funds raised for working capital and general corporate purposes. Auditor issued unmodified opinion.
Likely market impact
Strong profit growth, but deeply negative operating cash flow signals working capital strain. No fund use deviation is a positive.